Replication stress is a key driver of genomic instability giving rise to human disease, for instance cancer or developmental disorders. It is caused by a variety of defects such as lesions blocking replication (e.g. DNA interstrand crosslinks) or processes that lead to the exhaustion of DNA precursors. This generates under-replicated DNA and replication intermediates that can be rescued by repair processes requiring homologous recombination between sister chromatids. Often, cells exposed to replication stress enter mitosis with unresolved repair intermediates or under-replicated DNA, where the physical connections between sister chromatids will manifest as microscopically visible chromatin- or ultrafine bridges that interfere with chromosome segregation. Recent findings suggest that there are several pathways that resolve these chromatin bridges, but the precise mechanism remains ill understood. Moreover, the machinery that contribute to the resolution of chromatin bridges remain to be identified. We will combine quantitative mass spectrometry and microscopy based cell imaging techniques to identify and validate novel factors involved in the resolution of chromatin bridges. Using chromatin immunoprecipitation, we will isolate mitotic chromatin complexes and determine their composition by quantitative mass spectrometry. In collaboration with Holger Bastians (SP2), Matthias Dobbelstein (SP4) and Zuzana Storchová (SP8) we will characterize mitotic complexes in model systems with different types of replication stress. From the same complexes, we will analyze the bound DNA by next generation sequencing (in collaboration with the SP-Z) to determine sites where chromatin bridges form recurrently. Using microscopy (Zuzana Storchová, SP8), we will validate candidate proteins by their co-localization with known markers at distinct mitotic structures. The most promising candidates will be selected and analyzed further in order to precisely determine their function in the maintenance of genome stability. By acquiring a global multidimensional mitotic chromatin interactome through analysis of a range of different replication stress conditions we aim at identifying new classes of chromatin bridges and factors involved in their resolution.
Programme: FOR2800
SEEK ID: https://seek-for2800.de/projects/9
Public web page: https://for2800.de/cases/sub-project-6-proteomics-of-mitotic-inter-sister-chromatid-junctions/
Organisms: No Organisms specified
FAIRDOM PALs: No PALs for this Project
Project created: 8th Nov 2021
Related items
- People (2)
- Programmes (1)
- Institutions (1)
- Investigations (2+1)
- Studies (4+2)
- Assays (2+1)
- Data files (0+3)
- SOPs (4+3)
- Documents (2)
Our Research Unit addresses an important question on the origin of chromosome instability (CIN), which causes structural as well as numerical chromosome aberrations. Importantly, CIN and increased levels of chromosome aberrations are closely associated with many human diseases including cancer, neurodegenerative diseases and age-related syndromes and can act as key drivers for disease development and progression. An important condition that causes structural chromosome instability (S-CIN) leading ...
Projects: SP-3: A statistical modeling approach to identify common triggers for replication stress and mitotic chromosome missegregation, SP-1: Deciphering signaling pathways that promote accurate chromosome segregation after replication stress, SP-2: Molecular mechanisms of replication stress-induced mitotic chromosome missegregation, SP-4: Centrosome integrity as a determinant of replication stress and mitotic dysfunction, SP-5: Impaired chromosome integrity caused by mutations in members of the BTR complex, SP-6: Proteomics of mitotic inter sister chromatid junctions, SP-8: The causes of replication stress in response to whole chromosomal aneuploidy, SP-Z: NGS-based approaches for systematic analysis of genomic and chromosome instability Bernd Wollnik, Göttingen, SP9: Mutual impact of replication origin firing regulation and mitotic chromosome segregation
Web page: https://for2800.de/
Replication stress is one of the major causes for chromosomal instability which is a hallmark of cancer. Incomplete repair can lead to severe mitotic defects and ultra-fine anaphase bridges (UFBs) are a typical consequence. So far, five different classes of UFBs have been discribed: fragile sites-UFBs, centromeric-UFBs, telomeric-UFBs, homologous recombination-UFBs and rDNA-UFBs, which can be distinguished by their location and the way how they arise. Although previous studies have already proposed ...
Submitter: Angela Wieland
Studies: ChIP-MS proteomics in BLM depletable cells, ChIP-MS proteomics to identify novel interaction partners of FANCD2
Snapshots: No snapshots
Genomic instability is a hallmark of cancer and can be frequently induced by replication stress. Incomplete repair of replication intermediates can lead to persistent linkages between sister chromatides, detectable during mitosis as ultra-fine anaphase bridges (UFBs). The active resolution of UFBs via several UFB factors are crucial to prevent mitotic catastrophe, chromosomal missegregations or aneuploidy. Previous studies have already revealed that UFBs are processed by a distinct set of proteins, ...
Submitter: Angela Wieland
Studies: GFP/AID tagging of endogenous BLM for rapid protein depletion, Sister chromatid exchange assay of BLM depletable cell lines
Assays: No Assays
Snapshots: No snapshots
One of the main characteristics of BLM syndrome patients and BLM deficient cell lines is the enhanced occurence of sister chromatid exhange, detectable in metaphase chromosome spreads. Successful BLM depletion in our homozygous BLM-AID cell line was accompanied by a significant increase of sister chromatid exchange (SCE).
Submitter: Angela Wieland
Investigation: Impact of cell-cycle specific BLM depletion on ...
Assays: No Assays
Snapshots: No snapshots
To study how mitotic functions of BLM helicase contribute to genome stability, we genereated chromosomally stable HCT116 cell lines, in which BLM protein can be rapidly degraded in a cell-cycle specific manner. Using the CRISPR/Cas9 technology, a homology donor encoding an auxin-inducible degron (AID), GFP and a selection marker was inserted at the last coding exon of the endogenous BLM gene. To generate the homology donor, a modular cloning system was set up using the Golden Gate assembly strategy. ...
Submitter: Angela Wieland
Investigation: Impact of cell-cycle specific BLM depletion on ...
Assays: No Assays
Snapshots: No snapshots
FANCD2 ChIP-MS experiments in refined synchronized HCT116 cells with different types of replication stress are performed to identify additional proteins involved in the resolution of UFBs. Through reciprocal ChIP-MS and colocalization analysis by immunofluorescence experiments observed interactions will be validated. In collaboration with SP-Z promising candidates will be prioritized and subsequently tested for their contribution to the resolution of UFBs and chromosome segregation. In collaboration ...
Submitter: Angela Wieland
Investigation: Identification of factors involved in UFB resol...
Assays: ChIP-MS
Snapshots: No snapshots
In this study we can investigate the ability to pull down BLM in BLM-AID cells with its inserted GFP tag and use the BLM-depleted cell line as a control. The ChIP-MS analysis of BLM in synchronized cells can reveal new interaction partners invovled in the resolution of UFBs. On the other hand pulling down other UFB binding proteins in BLM depleted cells can help to understand the impact of cell-cycle specific BLM depletion on UFB resolution.
Submitter: Angela Wieland
Investigation: Identification of factors involved in UFB resol...
Assays: No Assays
Snapshots: No snapshots
Submitter: Angela Wieland
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Identification of factors involved in UFB resol...
CHIP-MS was performed with HeLa cells carrying a bacterial artifical chromosome for the expression of GFP-tagged PICH under it's endogenous promotor. Cells were treated with drugs to induce different types of ultra-fine bridges (UFBs). Treatments included: a) 24h exposure to 0.1 uM Aphidicolin, b) 24 hours exposure to 120 ng/ml mitomycin C, c) 6.5 hours incubation in 0.05 ug/ml nocodazol followed by a release into 0.1 uM ICRF-193 topoisomerase inhibitor.
Submitter: Markus Räschle
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Identification of factors involved in UFB resol...
Study: 1 hidden item
Creator: Angela Wieland
Submitter: Angela Wieland
Investigations: Identification of factors involved in UFB resol...
Studies: ChIP-MS proteomics to identify novel interactio... and 1 hidden item
Creator: Angela Wieland
Submitter: Angela Wieland
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Creator: Angela Wieland
Submitter: Angela Wieland
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Creator: Angela Wieland
Submitter: Angela Wieland
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Creator: Angela Wieland
Submitter: Angela Wieland
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Creator: Angela Wieland
Submitter: Angela Wieland
Investigations: No Investigations
Studies: No Studies
Assays: No Assays
Overview
Tags